Advertisement
Screener

ENTRADA THERAPEUTICS, INC. (TRDA) Auditor

ENTRADA THERAPEUTICS, INC. Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-02-26: Fiscal year end 2025-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Boston, Massachusetts.
  • 2025-02-27: Fiscal year end 2024-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Boston, Massachusetts.
  • 2024-03-13: Fiscal year end 2023-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Boston, Massachusetts.
  • 2023-08-08: Fiscal year end 2022-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Boston, Massachusetts.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-02-262025-12-31Ernst & Young LLP42Boston, MassachusettsNo
2025-02-272024-12-31Ernst & Young LLP42Boston, MassachusettsNo
2024-03-132023-12-31Ernst & Young LLP42Boston, MassachusettsNo
2023-08-082022-12-31Ernst & Young LLP42Boston, MassachusettsNo
2023-03-062022-12-31Ernst & Young LLP42Boston, MassachusettsNo
2022-03-152021-12-31Ernst & Young LLP42Boston, MassachusettsNo

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01
MACROGENICS INC (MGNX)United States$0.242B-20.11
Pyxis Oncology, Inc. (PYXS)United States$0.244B
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12
Lyell Immunopharma, Inc. (LYEL)United States$0.248B-1.32
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33
Cartesian Therapeutics, Inc. (RNAC)United States$0.231B-2.04
Akebia Therapeutics, Inc. (AKBA)United States$0.255B-10.35
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55